• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

33.53 -0.05 (-0.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,531,631
Open 33.12
Bid (Size) 33.00 (5,700)
Ask (Size) 33.89 (100)
Prev. Close 33.58
Today's Range 33.06 - 34.10
52wk Range 25.28 - 46.48
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum ↗
April 04, 2026
Via Chartmill
News headline image
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗
March 16, 2026
Viking Therapeutics develops clinical-stage therapies for metabolic and endocrine disorders, aiming to address unmet medical needs. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+14.5%
+14.5%
1 Month
+15.5%
+15.5%
3 Month
+12.1%
+12.1%
6 Month
-8.8%
-8.8%
1 Year
-10.2%
-10.2%

More News

Read More
News headline image
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗
March 16, 2026
Via The Motley Fool
TG Therapeutics Inc (NASDAQ:TGTX) Presents a Compelling Momentum Case with Strong Growth and Technical Setup ↗
March 14, 2026
Via Chartmill
News headline image
TG Therapeutics (TGTX) Q4 2025 Earnings Transcript ↗
February 26, 2026
Via The Motley Fool
TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook ↗
February 26, 2026
Via Chartmill
Topics Earnings
News headline image
Soleus Adds a Significant Number of Celcuity Shares ↗
February 13, 2026
Via The Motley Fool
News headline image
TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' ↗
February 09, 2026
Via Stocktwits
News headline image
Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares ↗
February 02, 2026
Via The Motley Fool
TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗
January 15, 2026
Via Stocktwits
TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug ↗
November 03, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 3, 2025 ↗
November 03, 2025
Via Benzinga
News headline image
Earnings Preview For TG Therapeutics ↗
October 31, 2025
Via Benzinga
News headline image
Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗
January 14, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗
January 13, 2026
Via Stocktwits
Topics Artificial Intelligence
These stocks are moving in today's after hours session ↗
January 13, 2026
Via Chartmill
News headline image
TG Therapeutics TGTX Q3 2025 Earnings Transcript ↗
November 27, 2025
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
November 11, 2025
Via Benzinga
News headline image
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗
November 10, 2025
Via Investor's Business Daily
News headline image
Hussman Sells Off All 21,000 CHKP Shares Valued At $4.65 Million ↗
November 03, 2025
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
November 03, 2025
Via Benzinga
News headline image
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗
November 03, 2025
Via Benzinga
News headline image
Highly Watched TG Therapeutics Smashes Profit Views — With A Caveat ↗
November 03, 2025
Via Investor's Business Daily
Topics Earnings
News headline image
Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗
October 16, 2025
Via Benzinga
News headline image
TG THERAPEUTICS INC (NASDAQ:TGTX) Shows High Growth Momentum and Technical Breakout Setup ↗
October 07, 2025
Via Chartmill

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 33.53
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 04/02/26 04:00 PM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 5.18B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap